当前位置:首页 - 行情中心 - 国药股份(600511) - 财务分析 - 现金流量表

国药股份

(600511)

  

流通市值:193.34亿  总市值:263.62亿
流通股本:5.53亿   总股本:7.55亿

现金流量表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金11,664,682,602.8254,186,457,995.9137,684,594,495.4624,255,287,154.73
收到的税费返还153,536.981,049,896.05908,303.13111,502.54
收到其他与经营活动有关的现金166,860,132.15289,149,874.92237,106,113.57202,605,339.73
经营活动现金流入的平衡项目0000
经营活动现金流入小计11,831,696,271.9554,476,657,766.8837,922,608,912.1624,458,003,997
购买商品、接受劳务支付的现金12,770,451,730.1748,496,799,804.8435,585,661,984.7623,087,312,495.65
支付给职工以及为职工支付的现金265,605,559.88847,889,302.22631,529,666.85439,133,537.82
支付的各项税费383,507,248.511,451,180,070.34984,685,107.35648,580,456.76
支付其他与经营活动有关的现金131,931,110.06954,131,491.95711,510,327.48449,034,646.99
经营活动现金流出的平衡项目0000
经营活动现金流出小计13,551,495,648.6251,750,000,669.3537,913,387,086.4424,624,061,137.22
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-1,719,799,376.672,726,657,097.539,221,825.72-166,057,140.22
二、投资活动产生的现金流量:
收回投资收到的现金18,561,622.517,878,681.737,625,926.527,625,926.52
取得投资收益收到的现金5,343.397,773,419.325,885,306.15,885,306.1
处置固定资产、无形资产和其他长期资产收回的现金净额83,440161,051.16152,008.295,350
收到的其他与投资活动有关的现金--57,755.2257,755.21
投资活动现金流入的平衡项目0000
投资活动现金流入小计18,650,405.915,813,152.2113,720,996.0413,664,337.83
购建固定资产、无形资产和其他长期资产支付的现金19,604,382.45145,124,184.2797,751,267.6866,566,292.6
投资支付的现金1,375,700---
投资活动现金流出的平衡项目0000
投资活动现金流出小计20,980,082.45145,124,184.2797,751,267.6866,566,292.6
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-2,329,676.55-129,311,032.06-84,030,271.64-52,901,954.77
三、筹资活动产生的现金流量:
取得借款收到的现金9,531,775203,195,997.9230,750,770.27167,196,067.45
收到其他与筹资活动有关的现金328,666,029.88276,474,938.47304,469,178.251,846,224.28
筹资活动现金流入平衡项目0000
筹资活动现金流入小计338,197,804.88479,670,936.37535,219,948.52169,042,291.73
偿还债务支付的现金100,000,000250,000,000251,269,489.8201,269,489.8
分配股利、利润或偿付利息支付的现金62,113,778.59780,138,629.31726,618,188.67678,671,669.89
其中:子公司支付给少数股东的股利、利润28,041,523.1770,560,925.0939,200,764.7922,734,291.68
支付其他与筹资活动有关的现金59,502,445.6781,708,180.85519,200,519.91151,132,747.75
筹资活动现金流出平衡项目0000
筹资活动现金流出小计221,616,224.261,111,846,810.161,497,088,198.381,031,073,907.44
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额116,581,580.62-632,175,873.79-961,868,249.86-862,031,615.71
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-1,605,547,472.61,965,170,191.68-1,036,676,695.78-1,080,990,710.7
加:期初现金及现金等价物余额10,798,318,043.178,833,147,851.498,833,147,851.498,833,147,851.49
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额9,192,770,570.5710,798,318,043.177,796,471,155.717,752,157,140.79
补充资料:
净利润-2,334,470,740.61-1,062,676,754.05
资产减值准备--388,870.07-9,440,883.24
固定资产和投资性房地产折旧-75,031,026.88-37,049,818.07
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-74,799,009.6-37,049,818.07
投资性房地产折旧-232,017.28--
无形资产摊销-38,286,751.8-19,112,224.7
长期待摊费用摊销-8,572,884.72-3,972,905.09
递延收益摊销-8,288,892--
处置固定资产、无形资产和其他长期资产的损失--83,443.4--460,355.57
固定资产报废损失-54,020.88-2,427.61
公允价值变动损失--10,817,458.31--34,725,094.18
财务费用-31,570,183.83-27,954,043.73
投资损失--358,951,819.35--197,452,278.72
递延所得税--7,194,611.2-7,711,790.54
其中:递延所得税资产减少--500,099.37-10,985,431.4
递延所得税负债增加--6,694,511.83--3,273,640.86
存货的减少--243,603,868.56--228,753,171.57
经营性应收项目的减少--292,548,102.02--1,878,943,628.28
经营性应付项目的增加-1,048,141,217.07-923,390,490.38
其他---19,141.08
现金的期末余额-10,798,318,043.17-7,752,157,140.79
减:现金的期初余额-8,833,147,851.49-8,833,147,851.49
公告日期2024-04-262024-03-212023-10-252023-08-24
审计意见(境内)标准无保留意见
TOP↑